CN103719997B - A kind of guava solid beverage - Google Patents
A kind of guava solid beverage Download PDFInfo
- Publication number
- CN103719997B CN103719997B CN201410006209.9A CN201410006209A CN103719997B CN 103719997 B CN103719997 B CN 103719997B CN 201410006209 A CN201410006209 A CN 201410006209A CN 103719997 B CN103719997 B CN 103719997B
- Authority
- CN
- China
- Prior art keywords
- guava leaf
- solid beverage
- rehmannia
- xylitol
- chinese yam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000508269 Psidium Species 0.000 title claims abstract description 60
- 235000013361 beverage Nutrition 0.000 title claims abstract description 29
- 239000007787 solid Substances 0.000 title claims abstract description 29
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 26
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 26
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 26
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 26
- 238000001914 filtration Methods 0.000 claims abstract description 26
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 25
- 239000009636 Huang Qi Substances 0.000 claims abstract description 24
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 23
- 241000405414 Rehmannia Species 0.000 claims abstract description 23
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 21
- 229960002675 xylitol Drugs 0.000 claims abstract description 21
- 235000010447 xylitol Nutrition 0.000 claims abstract description 21
- 239000000811 xylitol Substances 0.000 claims abstract description 21
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 15
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 15
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 239000000706 filtrate Substances 0.000 claims abstract description 7
- 238000005507 spraying Methods 0.000 claims abstract 3
- 238000010237 hybrid technique Methods 0.000 claims abstract 2
- 239000007788 liquid Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 6
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000007667 floating Methods 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 210000002784 stomach Anatomy 0.000 abstract description 19
- 210000003734 kidney Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 9
- 239000004480 active ingredient Substances 0.000 abstract description 7
- 230000000638 stimulation Effects 0.000 abstract description 4
- 230000035622 drinking Effects 0.000 abstract description 3
- 235000019640 taste Nutrition 0.000 abstract description 2
- 210000000952 spleen Anatomy 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 235000013616 tea Nutrition 0.000 description 11
- 230000007170 pathology Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 230000002218 hypoglycaemic effect Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010041660 Splenomegaly Diseases 0.000 description 3
- 241001122767 Theaceae Species 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 2
- 206010017788 Gastric haemorrhage Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010048469 Kidney enlargement Diseases 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960000673 dextrose monohydrate Drugs 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
- A23L2/74—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration using membranes, e.g. osmosis, ultrafiltration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Water Supply & Treatment (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention discloses a kind of guava leaf solid beverage, raw material obtains after pretreatment, decoction, filtration, merging filtrate, concentrated filtrate, spraying dry and hybrid technique, and raw material through weight proportion is: Guava Leaf 6000 ~ 7500g, the raw Radix Astragali 1000 ~ 1500g, Chinese yam 3500 ~ 4000g, matrimony vine 5500 ~ 6500g, Fructus Corni 1600 ~ 2000g, prepared rhizome of rehmannia 3000 ~ 4500g, maltose 1000 ~ 2000g, xylitol 3600 ~ 4800g, D-sorbite 450 ~ 550g.Drink guava leaf solid beverage of the present invention for a long time, not only can reduce blood-sugar content significantly, can also play and adjust taste, protect effect of kidney, to drink for a long time in addition or drinking of said beverage effectively can evade active ingredient to GI stimulation on an empty stomach.
Description
technical fieldthe present invention relates to a kind of guava leaf solid beverage, belong to teas field of beverage.
background technology
Guava Leaf has another name called chicken and vows tea, and bar in kind peach leaf, fiber crops, that pulls out leaf, pulls out the young heart, the guava heart etc., is dry leaf and the tender stem of band leaf of guava, gathers in spring, summer, dry or using fresh herb.Guava Leaf is that square round shape is oval to oval, and many shrinkages are curling or broken, long 5 ~ 12cm, wide 3 ~ 5cm, tip circle or short point, base portion is blunt to circular, the full edge in edge, the light brown brown of upper surface, without hair, lower surface taupe brown, close by pubescence, master pulse and lateral vein all swell, and lateral vein is linked to be limit arteries and veins at nearly leaf margin place; Long 3 ~ the 6cm of petiole, keratin and crisp, frangibility; Flat four prismatics of tender stem, close by pubescence, gas delicate fragrance, puckery, micro-sweetness and bitterness.America natives and the fresh leaf of the useful guava of the Yunnan Blang masses treat the custom of enteritis, dysentery.Japan's tender leaf of guava, bud tea making, be used for the treatment of diabetes, hypertension, good effect and safely, have no side effect.The traditional Chinese medical science is thought: Guava Leaf is flat, sweet-puckery flavor, enters spleen, stomach, large intestine, Liver Channel, have promote the production of body fluid to quench thirst, relieving restlessness, astringing to arrest diarrhea, anti-inflammation hemostasia, the function such as antipruritic, often drinking can be clearing heat and detoxicating, prevents and treats enteritis and diarrhoea.
Modern pharmacology research proves, containing flavone compound in Guava Leaf, the metabolism (CN102217686A) of sugar, fat can be adjusted to the utilization of sugar without pathology (CN102920785A) or by the combination of single-minded acceptor on promotion insulin and target cell membrane by improving human peripheral's tissue, there is effect hypoglycemic, antibacterial, antiviral, promoting blood circulation and removing blood stasis.At present, to Guava Leaf main application approach be extract the active ingredient general flavone (CN10292078A, CN101703577A, CN1810797) of Guava Leaf to be applied to clinical treatment as medicinal active ingredient or to be configured to Chinese and Western medicine, oral or injection arrives result for the treatment of; Or utilize the extract of Guava Leaf and other be configured to tea-drinking and drink for a long time (CN102217686A).
But the course of disease of diabetes is long and complicated, although to inject or oral extractive of general flavone/medicament can treat diabetes and hypertension, hyperlipidemia complication, need to undertake heavy financial burden and patient can produce dependence and the resistance to the action of a drug to medicine.Diabetes there will be diabetic complication usually along with illness, except hypertension and high fat of blood, comparatively serious to the harm of kidney, and existing renal failure or uremia occur time serious.Under normal circumstances, hypoglycemic medicine needs to take before the meal just can effectively play its drug effect, but because do not have protection and the buffering of food, active ingredient is directly left in stomach through throat, with intestines wall and coat of the stomach Long Term Contact; The drug effect of extract or medicament is stronger, and diabetes are again the therapeutic processes of a longer-term, and long-term drug therapy is to the various internal organs of patient, and the injury of kidney, spleen, stomach and enteron aisle is very serious.
summary of the inventionthe object of the invention is to provide a kind of guava leaf solid beverage for the deficiencies in the prior art, take Guava Leaf as function of polysaccharide component, and the natural materials such as the Radix Astragali of proportioning life simultaneously, Chinese yam, matrimony vine, Fructus Corni and prepared rhizome of rehmannia also carry out fine finishining; Falling the hypoglycemic function simultaneously regulating body parts, function of spleen and stomach regulating also protects kidney; Can avoid because long-term empty stomach drinks the active ingredient that causes to GI stimulation simultaneously; The shortcoming that natural plants curative effect is slow, mouthfeel is poor can also be evaded.Based on above-mentioned opinion, the present invention is achieved in that
A kind of guava leaf solid beverage, composition of raw materials is:
The raw Radix Astragali 1000 ~ 1500g of Guava Leaf 6000 ~ 7500g
Matrimony vine 5500 ~ 6500g Chinese yam 3500 ~ 4000g
Fructus Corni 1600 ~ 2000g prepared rhizome of rehmannia 3000 ~ 4500g
Maltose 1000 ~ 2000g xylitol 3600 ~ 4800g
D-sorbite 450 ~ 550g.
The present invention also provides a kind of production method of guava leaf solid beverage, comprises the following steps:
(1) pretreatment of raw material: by Guava Leaf, the raw Radix Astragali, Chinese yam, matrimony vine, Fructus Corni and prepared rhizome of rehmannia, remove impurity and part of going mouldy, clean, dry, be broken into the fragment that length is 3 ~ 5cm respectively;
(2) decoct, coarse filtration: pretreated raw material to be added water respectively 55 ~ 75 times amount according to pulp furnish, decocts 4 ~ 6 times, each 15 ~ 25min; Respectively coarse filtration is carried out to above-mentioned each decoction liquor, adopts 100 orders, 200 orders, 300 orders and 400 mesh sieve thin,tough silk successively to filter, remove floating foreign material and leave and take filtrate acquisition coarse filtration liquid;
(3) merge coarse filtration liquid and carry out fine filtering: merge above-mentioned coarse filtration liquid and carry out fine filtering, be the miillpore filter of 0.45 μm, 0.22 μm successively by aperture, operating pressure 0.3MPa, obtains fine filtering liquid;
(4) concentrated, freeze drying: it is 1 ± 0.01 that fine filtering liquid is concentrated into relative density in reduced pressure concentration tank, and concentrate is obtained instant powder by spray drying technology;
(5) mix, pack: maltose, xylitol and D-sorbite were pulverized 200 ~ 300 mesh sieve thin,tough silk and obtain fine powder, maltose, xylitol and D-sorbite fine powder are mixed sterilizing with the instant powder of step 4 gained, according to the dose package often wrapping 5 ± 0.1g.
The Radix Astragali of the present invention, nature and flavor are sweet, return lung, spleen, liver, kidney channel, have the effect strengthening immunity of organisms, protect the liver, regulate blood sugar, coronary artery dilator, improve myocardial blood supply.And record in " Japan hanako materia medica ", " Chinese yam helps the five internal organs, strengthening the bones and muscles "; Being described as " Chinese yam energy kidney-nourishing gas, strengthening the spleen and stomach " to Chinese yam in Compendium of Material Medica.Containing abundant LBP-X, carotenoid, lutein and matrimony vine seed element in matrimony vine, tool increases significantly the significant curative effect of body immunity, moistening lung, removing heat to brighten vision.The Radix Astragali, Chinese yam and matrimony vine have complementary effect at the Spleen-stomach Prescriptions mask of adjustment body.
Fructus Corni of the present invention is used for kidney deficiency and liver, containing abundant Fructus Corni tannic acid, has significant therapeutic effect to IDD tool; Prepared rhizome of rehmannia, taste is sweet, tepor, enters liver kidney two warp, enriching yin of can enriching blood, benefit lean marrow, also significant enriching yin and nourishing kidney effect of tool.
Guava leaf solid beverage of the present invention, Guava Leaf has the curative effect effectively reducing blood sugar, and auxiliary material Chinese yam, matrimony vine and Radix Astragali reasonable compatibility, both can reduce blood sugar, strengthens the immunocompetence of body and the ability of function of spleen and stomach regulating simultaneously; And Fructus Corni in raw material and prepared rhizome of rehmannia, significantly improve the protection to human internal organ, especially kidney; Drink guava leaf solid beverage of the present invention for a long time; not only can reduce blood-sugar content significantly; can also function of spleen and stomach regulating, protection kidney, the reasonable compatibility of medicine is avoided because to drink for a long time or empty stomach drinks the active ingredient that causes to GI stimulation and damage while reaching hypoglycemic object.
accompanying drawing explanationfig. 1: process chart of the present invention.
detailed description of the inventionthe present invention is further illustrated to use nonlimiting examples below.Embodiment 1:
Get Guava Leaf 6000g, raw Radix Astragali 1000g, matrimony vine 5500g, Chinese yam 3500g, Fructus Corni 1600g and prepared rhizome of rehmannia 3000g, remove impurity and part of going mouldy, clean, dry, be broken into the fragment that length is 3 ~ 5cm respectively; Add water 55 ~ 75 times amount respectively, decocts 4 ~ 6 times, each 15 ~ 25min in ceramic pan; Respectively coarse filtration is carried out to each decoction liquor, adopts 100 orders, 200 orders, 300 orders and 400 mesh sieve thin,tough silk successively to filter, remove floating foreign material and leave and take filtrate acquisition coarse filtration liquid; Merge coarse filtration liquid and carry out fine filtering, be the miillpore filter of 0.45 μm, 0.22 μm successively by aperture, operating pressure 0.3MPa, obtains fine filtering liquid; It is 1 ± 0.01 that fine filtering liquid is concentrated into relative density in reduced pressure concentration tank, and concentrate is obtained instant powder by spray drying technology; 1200g maltose, 3600g xylitol and 500g D-sorbite were pulverized 200 ~ 300 mesh sieve thin,tough silk and obtained fine powder, maltose, xylitol and D-sorbite fine powder were mixed sterilizing with instant powder, according to the dose package often wrapping 5g.All operations all performs with reference to standard GB/T 12695 " drink enterprise GMP ".
Embodiment 2:
Step is identical with embodiment 1 with technique, and to be the pulp furnish of Guava Leaf solid tea beverage be difference: Guava Leaf 7500g, raw Radix Astragali 1500g, Chinese yam 4000g, matrimony vine 6500g, Fructus Corni 2000g, prepared rhizome of rehmannia 4500g, xylitol 4800g.
Embodiment 3:
Step is identical with embodiment 1 with technique, and to be the pulp furnish of Guava Leaf solid tea beverage be difference: Guava Leaf 6000g, raw Radix Astragali 1500g, Chinese yam 4000g, matrimony vine 6500g, Fructus Corni 2000g, prepared rhizome of rehmannia 4500g, xylitol 3800g.
Embodiment 4:
Step is identical with embodiment 1 with technique, and to be the pulp furnish of Guava Leaf solid tea beverage be difference: Guava Leaf 7500g, raw Radix Astragali 1000g, Chinese yam 3500g, matrimony vine 5500g, Fructus Corni 1600g, prepared rhizome of rehmannia 3000g, xylitol 4200g.
Embodiment 5:
Step is identical with embodiment 1 with technique, and to be the pulp furnish of Guava Leaf solid tea beverage be difference: Guava Leaf 6500g, raw Radix Astragali 1200g, Chinese yam 3700g, matrimony vine 6000g, Fructus Corni 1700g, prepared rhizome of rehmannia 3500g, xylitol 4000g.
Embodiment 6:
Step is identical with embodiment 1 with technique, and to be the pulp furnish of Guava Leaf solid tea beverage be difference: Guava Leaf 7000g, raw Radix Astragali 1400g, Chinese yam 3700g, matrimony vine 6500g, Fructus Corni 1800g, prepared rhizome of rehmannia 4000g, xylitol 4000g.
Embodiment 7:
Step is identical with embodiment 1 with technique, and to be the pulp furnish of Guava Leaf solid tea beverage be difference: Guava Leaf 6500g, raw Radix Astragali 1300g, Chinese yam 3500g, matrimony vine 6500g, Fructus Corni 2000g, prepared rhizome of rehmannia 4000g, xylitol 4000g.
Contrast test:
Configure 6 groups of control group solid beverages, contrast test is carried out: naive mice does not inject any tea product with the beverage of embodiment of the present invention 1-7 gained, (5g beverage is dissolved in 50ml water control group and the embodiment group beverage that oral cavity injection is corresponding respectively, every injected in mice amount is 10ml, and inject time is ︰ 00 in early morning 6).Every mouse ︰ 00 at noon every day 12 lumbar injection 2ml concentration is the glucose of 3mg/ml, and every day normally throws something and feeds and raises, and observes mouse symptom in process of throwing something and feeding; 85-90 days every days of test gather mouse blood carry out blood sugar test, collect mouse whole day after urine carry out albuminuria detection, and after off-test in 90 days, anatomic observation organ disease situation is carried out to mouse.Result of the test is as shown in table 1: wherein blood-sugar content and proteinuria level are the mean value of the measurement result of 85-90 days:
Table 1: control mice result of the test
Group | Blood sugar (mmol/L) | Urine proteins (mg/24h) | Spleen, stomach, kidney symptom or behavior symptom |
Blank group | 3.82 | 80 | Kidney, splenomegaly |
Control group 1 | 3.29 | 35 | Intestines wall is hemorrhage, gastric bleeding, kidney, splenomegaly |
Control group 2 | 3.75 | 40 | Intestines wall is hemorrhage, kidney enlargement |
Control group 3 | 3.77 | 38 | Gastrointestinal bleeding, mouse have symptom of diarrhea |
Control group 4 | 3.40 | 36 | Kidney enlargement, mouse have abdominal distension symptom |
Control group 5 | 3.39 | 33 | Coat of the stomach and intestines wall have blutpunkte, and mouse has abdominal distension symptom |
Control group 6 | 3.71 | 40 | Splenomegaly, gastric bleeding |
Embodiment 1 | 3.20 | 28 | Without pathology |
Embodiment 2 | 3.21 | 27 | Without pathology |
Embodiment 3 | 3.22 | 26 | Without pathology |
Embodiment 4 | 3.23 | 27 | Without pathology |
Embodiment 5 | 3.18 | 22 | Without pathology |
Embodiment 6 | 3.18 | 20 | Without pathology |
Embodiment 7 | 3.17 | 21 | Without pathology |
Above-mentioned control group 1 formula is: Guava Leaf 6500g; Control group 2 is filled a prescription as matrimony vine 6500g, raw Radix Astragali 1300g, Chinese yam 3500g; Contrast 3 formula is: Fructus Corni 2000g, prepared rhizome of rehmannia 4000g; Control group 4 formula is: control group 1+ control group 2; The formula of control group 5 is: control group 1+ control group 3; The formula of control group 6 is: control group 2+ control group 3.
As shown in Table 1, control group mice is when continuous injectable dextrose monohydrate, and blood-sugar content and urine protein content are very high, and urine protein content is the important indicator evaluating diabetic nephropathy, and urine protein content height illustrates the renal function generation pathology of mouse.And simple take Guava Leaf as control group 1, although can reduce blood sugar and urine protein content significantly, long-term empty stomach is drunk and is caused stomach and intestines suffer damage, and kidney and spleen also have enlargement situation to occur.And simple take control group 2 and/or control group 3 beverage, although can protect stomach and intestine or spleen kidney, hypoglycemic effect is not good, and because blood-sugar content occupies high, concurrent kidney, spleen, stomach enlargement symptom also occur.The hypoglycemic effect of control group 4 and control group 5 beverage is slightly desirable, but, there is the mouse of 40-50% frequent appearance after the 55-60d of test to suffer from diarrhoea or abdominal distension symptom.And the solid beverage of embodiments of the invention 1-7; the while of falling hypoglycemic significantly, also can effectively reduce the content of viscous albumen in urine, for internal organ protected effect clearly; process of the test small mouse is acted normally, and does not also find that pathology appears in any internal organs after dissecting.
The above results illustrates, solid tea beverage of the present invention, not only can effectively reduce blood sugar, has the health-care efficacy of function of spleen and stomach regulating, protection kidney simultaneously; The reasonable compatibility of medicine is avoided when reaching the object of hypoglycemic because drinking or drink on an empty stomach the active ingredient that causes for a long time to GI stimulation and damage.
Above-mentioned example just for technical conceive of the present invention and technical characterstic are described, can not limit the scope of the invention with this.The equivalent transformation that all essence according to the present invention is done or modification, all should be encompassed within protection scope of the present invention.
Claims (8)
1. a guava leaf solid beverage, is characterized in that, is obtained through pretreatment of raw material, decoction, filtration, merging filtrate, concentrated filtrate, spraying dry and hybrid technique by the raw material of following weight proportion:
The raw material of above-mentioned guava leaf solid beverage consists of:
The raw Radix Astragali 1000 ~ 1500g of Guava Leaf 6000 ~ 7500g
Matrimony vine 5500 ~ 6500g Chinese yam 3500 ~ 4000g
Fructus Corni 1600 ~ 2000g prepared rhizome of rehmannia 3000 ~ 4500g
Maltose 1000 ~ 2000g xylitol 3600 ~ 4800g
D-sorbite 450 ~ 550g;
The production method of above-mentioned guava leaf solid beverage comprises the steps:
(1) pretreatment of raw material: by Guava Leaf, the raw Radix Astragali, Chinese yam, matrimony vine, Fructus Corni and prepared rhizome of rehmannia, remove impurity and part of going mouldy, clean, dry, be broken into the fragment that length is 3 ~ 5cm respectively;
(2) decoct, coarse filtration: pretreated raw material to be added water respectively 55 ~ 75 times amount according to pulp furnish, decocts 4 ~ 6 times, each 15 ~ 25min; Respectively coarse filtration is carried out to above-mentioned each decoction liquor, adopts 100 orders, 200 orders, 300 orders and 400 mesh sieve thin,tough silk successively to filter, remove floating foreign material and leave and take filtrate acquisition coarse filtration liquid;
(3) merge coarse filtration liquid and carry out fine filtering: merge above-mentioned coarse filtration liquid and carry out fine filtering, be the miillpore filter of 0.45 μm, 0.22 μm successively by aperture, operating pressure 0.3MPa, obtains fine filtering liquid;
(4) concentrated, spraying dry: it is 1 ± 0.01 that fine filtering liquid is concentrated into relative density in reduced pressure concentration tank, and concentrate is obtained instant powder by spray drying technology;
(5) mix, pack: maltose, xylitol and D-sorbite were pulverized 200 ~ 300 mesh sieve thin,tough silk and obtain fine powder, and gained fine powder was mixed sterilizing with the instant powder of step 4 gained, according to the dose package often wrapping 5 ± 0.1g.
2. guava leaf solid beverage according to claim 1, is characterized in that, described pulp furnish is:
The raw Radix Astragali 1000g of Guava Leaf 6000g
Matrimony vine 5500g Chinese yam 3500g
Fructus Corni 1600g prepared rhizome of rehmannia 3000g
Maltose 1200g xylitol 3600g
D-sorbite 500g.
3. guava leaf solid beverage according to claim 1, is characterized in that, described pulp furnish is:
The raw Radix Astragali 1500g of Guava Leaf 7500g
Matrimony vine 6500g Chinese yam 4000g
Fructus Corni 2000g prepared rhizome of rehmannia 4500g
Maltose 1200g xylitol 4800g
D-sorbite 500g.
4. guava leaf solid beverage according to claim 1, is characterized in that, described pulp furnish is:
The raw Radix Astragali 1500g of Guava Leaf 6000g
Matrimony vine 6500g Chinese yam 4000g
Fructus Corni 2000g prepared rhizome of rehmannia 4500g
Maltose 1200g xylitol 3800g
D-sorbite 500g.
5. guava leaf solid beverage according to claim 1, is characterized in that, described pulp furnish is:
The raw Radix Astragali 1000g of Guava Leaf 7500g
Matrimony vine 5500g Chinese yam 3500g
Fructus Corni 1600g prepared rhizome of rehmannia 3000g
Maltose 1200g xylitol 4200g
D-sorbite 500g.
6. guava leaf solid beverage according to claim 1, is characterized in that, described pulp furnish is:
The raw Radix Astragali 1200g of Guava Leaf 6500g
Matrimony vine 6000g Chinese yam 3700g
Fructus Corni 1700g prepared rhizome of rehmannia 3500g
Maltose 1200g xylitol 4000g
D-sorbite 500g.
7. guava leaf solid beverage according to claim 1, is characterized in that, described pulp furnish is:
The raw Radix Astragali 1400g of Guava Leaf 7000g
Matrimony vine 6500g Chinese yam 3700g
Fructus Corni 1800g prepared rhizome of rehmannia 4000g
Maltose 1200g xylitol 4000g
D-sorbite 500g.
8. guava leaf solid beverage according to claim 1, is characterized in that, described pulp furnish is:
The raw Radix Astragali 1300g of Guava Leaf 6500g
Matrimony vine 6500g Chinese yam 3500g
Fructus Corni 2000g prepared rhizome of rehmannia 4000g
Maltose 1200g xylitol 4000g
D-sorbite 500g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410006209.9A CN103719997B (en) | 2014-01-07 | 2014-01-07 | A kind of guava solid beverage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410006209.9A CN103719997B (en) | 2014-01-07 | 2014-01-07 | A kind of guava solid beverage |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103719997A CN103719997A (en) | 2014-04-16 |
CN103719997B true CN103719997B (en) | 2016-01-20 |
Family
ID=50444491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410006209.9A Expired - Fee Related CN103719997B (en) | 2014-01-07 | 2014-01-07 | A kind of guava solid beverage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103719997B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104305460A (en) * | 2014-10-13 | 2015-01-28 | 王林林 | Making method of psidium guajava health crystal grains |
CN106581169A (en) * | 2016-12-14 | 2017-04-26 | 佛山科学技术学院 | Drying method of guava leaves |
CN107183466A (en) * | 2017-05-23 | 2017-09-22 | 安徽元麦凡康食品有限公司 | A kind of auxiliary hyperglycemic solid beverage |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101322757A (en) * | 2008-07-28 | 2008-12-17 | 北京润德康医药技术有限公司 | Medicament composition for treating diabetes and method for preparing the same |
WO2010005438A1 (en) * | 2008-07-10 | 2010-01-14 | Amerilab Technologies, Inc. | Method of treating migraine using guava |
CN102441090A (en) * | 2011-12-20 | 2012-05-09 | 辽宁兴海制药有限公司 | Immunoregulation oral liquid |
-
2014
- 2014-01-07 CN CN201410006209.9A patent/CN103719997B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010005438A1 (en) * | 2008-07-10 | 2010-01-14 | Amerilab Technologies, Inc. | Method of treating migraine using guava |
CN101322757A (en) * | 2008-07-28 | 2008-12-17 | 北京润德康医药技术有限公司 | Medicament composition for treating diabetes and method for preparing the same |
CN102441090A (en) * | 2011-12-20 | 2012-05-09 | 辽宁兴海制药有限公司 | Immunoregulation oral liquid |
Also Published As
Publication number | Publication date |
---|---|
CN103719997A (en) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (en) | Health-care food for preventing diabetes | |
CN103689296B (en) | Feed for ewe at later pregnancy and lactation period and preparation method thereof | |
CN102178100B (en) | Low-tryptophan feed for hybrid chicken and preparation method of the low-tryptophan feed | |
CN103734428B (en) | A kind of glossy privet fruit health-care tea improving immunity and preparation method thereof | |
CN104351573A (en) | Mixed feed for treating cow hypogalactia and preparation method thereof | |
CN103653148B (en) | Guava leaf liquid beverage | |
CN104082672B (en) | A kind of health-preserving porridge with effect of lowering blood sugar and preparation method thereof | |
CN103549415A (en) | Composition with biological traditional Chinese medicinal prescription for relieving fatigue, invigorating the kidney and strengthening yang, traditional Chinese medicinal preparation, preparation method and application thereof | |
CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
CN103719997B (en) | A kind of guava solid beverage | |
CN104472789A (en) | Fructus sophorae tea for loosening bowels to relieve constipation and preparation method of fructus sophorae tea | |
KR100591539B1 (en) | Dietary supplement composition | |
KR20140034620A (en) | Composition for preventing or treating diabetbes mellitus disease containing extract of plants | |
CN104431772A (en) | Flour-made food capable of lubricating intestines and detoxifying and preparation method of flour-made food | |
CN104206595A (en) | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof | |
CN104304602A (en) | Pagoda tree fruit tea capable of softening blood vessels and preparation method thereof | |
CN104256165A (en) | Functional feed for preventing and treating chronic swine plague and preparation method of functional feed | |
CN101336965B (en) | Chinese prepared medicine for improving sugar tolerance and reducing blood sugar and preparation method thereof | |
KR101732483B1 (en) | Composition for prevention, improvement or treatment of peripheral neuropathy comprising Forsythiae Fructus extract as effective component | |
KR101095834B1 (en) | Natural tea composition prescribed based on patient's physical constitution | |
KR100850503B1 (en) | Composition for improving erectile dysfunction and erection maintenance containing the extract of crude drug complex | |
CN103181557A (en) | Nutritious food with slimming function and preparation method thereof | |
CN102793826B (en) | Traditional Chinese medicine for treating hypertension early-stage kidney damage and preparation method thereof | |
CN108277135A (en) | A kind of eucommia health care wine and preparation method | |
CN107006851A (en) | A kind of health food for improving sleep and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160120 Termination date: 20200107 |
|
CF01 | Termination of patent right due to non-payment of annual fee |